Clinical Trial Update: Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection [NA]

View source ↗

Summary

A completed clinical trial evaluated Arabinoxylan Rice Bran (MGN-3/Biobran) for hepatocellular carcinoma and hepatitis B/C infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatocellular Carcinoma

Drugs mentioned

• Biobran MGN-3 (arabinoxylan from rice bran)

Snippet

Sponsor: The 108 Military Central Hospital | Conditions: Hepatocellular Carcinoma, Hepatitis B | NA | Status: COMPLETED